Stocosil Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Out of Business

Stocosil General Information

Description

Operator of a pharmaceutical company designed to develop anti-hypertension drugs. The company's drugs help to treat cholesterol, enabling healthcare providers to treat their patients.

Contact Information

Website
www.stocosil.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Primary Office
  • 17870 Castleton Street
  • Suite 250
  • CA 91748
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Stocosil Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 29-Sep-2020 00.000 Completed Out of Business
1. Seed Round 12-Jul-2016 00.000 00.000 Completed Generating Revenue
To view Stocosil’s complete valuation and funding history, request access »

Stocosil Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial